Literature DB >> 8825273

Auditory and vestibular system findings in patients with vertebrobasilar dolichoectasia.

S Passero1, D Nuti.   

Abstract

Impairment of the auditory-vestibular system has been reported in patients with vertebrobasilar dolichoectasia (VBD), but little is known about the underlying cause of the symptoms. Auditory testing (pure tone audiometry, auditory brain stem response and stapedius reflex) and vestibular tests (assessment of nystagmus, eye tracking tests, caloric test and rotational test) were performed in 23 patients with auditory-vestibular symptoms and/or cranial nerve impairment associated with VBD. Specific evidence of auditory and/or vestibular system impairment was observed in 19 cases (83%). Among patients with abnormal test findings, 47% had evidence suggesting peripheral impairment, 16% evidence suggesting central dysfunction, and 37% evidence suggesting both peripheral and central dysfunction. Although compression of the vestibulocochlear nerve plays an important role in the genesis of the auditory-vestibular dysfunction in patients with VBD, mechanism such as brain stem-cerebellar ischemia and impaired blood supply to the vestibular labyrinth may be just as important.

Entities:  

Mesh:

Year:  1996        PMID: 8825273     DOI: 10.1111/j.1600-0404.1996.tb00170.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  3 in total

1.  Three-dimensional visualization of vertebrobasilar system aneurysms in a vertigo patient.

Authors:  Shou-Jen Wang; Jeng-Wen Chen; Yi-Ho Young
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-09-19       Impact factor: 2.503

2.  Recurrent facial hemiparesis due to dolichoectatic vertebrobasilar artery: an unusual and ignored cause.

Authors:  Vijay Nath Mishra; Rameshwar Nath Chaurasia; Shailesh Gupta; Deepika Joshi
Journal:  BMJ Case Rep       Date:  2013-03-15

3.  Vestibulocochlear Symptoms Caused by Vertebrobasilar Dolichoectasia.

Authors:  Gene Huh; Yun Jung Bae; Hyun Jun Woo; Jung Hyun Park; Ja-Won Koo; Jae-Jin Song
Journal:  Clin Exp Otorhinolaryngol       Date:  2019-09-17       Impact factor: 3.372

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.